These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2699071)

  • 1. Bladder tumour treatment in the aarhus region. 25 years of experience.
    Sell A; Jakobsen A; Mommsen S; Steenholdt S
    Scand J Urol Nephrol Suppl; 1989; 125():107-14. PubMed ID: 2699071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer.
    Freiha F; Reese J; Torti FM
    J Urol; 1996 Feb; 155(2):495-9; discussion 499-500. PubMed ID: 8558644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
    Segal R; Winquist E; Lukka H; Chin JL; Brundage M; Markman BR;
    Can J Urol; 2002 Oct; 9(5):1625-33. PubMed ID: 12431323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience.
    Stöckle M; Meyenburg W; Wellek S; Voges GE; Rossmann M; Gertenbach U; Thüroff JW; Huber C; Hohenfellner R
    J Urol; 1995 Jan; 153(1):47-52. PubMed ID: 7966789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trials of adjuvant and neoadjuvant chemotherapy in bladder cancer.
    Dimopoulos MA; Galani E
    Semin Urol Oncol; 2001 Feb; 19(1):59-65. PubMed ID: 11246736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
    Lehmann J; Franzaring L; Thüroff J; Wellek S; Stöckle M
    BJU Int; 2006 Jan; 97(1):42-7. PubMed ID: 16336326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing cystectomy and perioperative chemotherapy in the treatment of muscle invasive bladder cancer.
    Izawa JI; Chin JL; Winquist E
    Can J Urol; 2006 Jun; 13 Suppl 3():48-53. PubMed ID: 16818012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes of mortality rate for cervical cancer during 1970's and 1990's periods in China].
    Yang L; Huangpu XM; Zhang SW; Lu FZ; Sun XD; Sun J; Mu R; Li LD; Qiao YL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):386-90. PubMed ID: 12974079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Flow cytometry in diagnosis and treatment of bladder tumor].
    Sun XJ; Song ZL; Wu DC
    Zhonghua Wai Ke Za Zhi; 1994 Mar; 32(3):178-80. PubMed ID: 7842912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation.
    Sternberg CN
    Semin Oncol; 2007 Apr; 34(2):122-8. PubMed ID: 17382795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy for bladder cancer.
    Sternberg CN; Calabró F
    Expert Rev Anticancer Ther; 2005 Dec; 5(6):987-92. PubMed ID: 16336089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end point.
    Decensi A; Torrisi R; Bruno S; Costantini M; Curotto A; Nicolò G; Malcangi B; Baglietto L; Bruttini GP; Gatteschi B; Rondanina G; Varaldo M; Perloff M; Malone WF; Bruzzi P
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1071-8. PubMed ID: 11045790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant and neoadjuvant chemotherapy for urothelial carcinoma.
    McCaffrey JA; Herr HW
    Surg Oncol Clin N Am; 1997 Oct; 6(4):667-81. PubMed ID: 9309087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience.
    Choong NW; Quevedo JF; Kaur JS
    Cancer; 2005 Mar; 103(6):1172-8. PubMed ID: 15700264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy in patients with invasive bladder cancer.
    Vaughn DJ; Malkowicz SB
    Urol Clin North Am; 2005 May; 32(2):231-7. PubMed ID: 15862620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus review of the clinical utility of DNA cytometry in bladder cancer. Report of the DNA Cytometry Consensus Conference.
    Wheeless LL; Badalament RA; de Vere White RW; Fradet Y; Tribukait B
    Cytometry; 1993; 14(5):478-81. PubMed ID: 8354118
    [No Abstract]   [Full Text] [Related]  

  • 17. Opportunities with combined modality therapy for selective organ preservation in muscle-invasive bladder cancer.
    Colvett KT; Althausen AF; Bassil B; Heney NM; McGovern FV; Young HH; Kaufman DS; Zietman AL; Shipley WU
    J Surg Oncol; 1996 Nov; 63(3):201-8. PubMed ID: 8944067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties.
    Choueiri TK; Raghavan D
    Nat Clin Pract Oncol; 2008 Aug; 5(8):444-54. PubMed ID: 18577983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing locally advanced bladder cancer.
    Lehmann J; Retz M; Siemer S; Kamradt J; Wullich B; Stöckle M
    Expert Rev Anticancer Ther; 2002 Dec; 2(6):656-66. PubMed ID: 12503211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder cancer.
    Ozen H
    Curr Opin Oncol; 1997 May; 9(3):295-300. PubMed ID: 9229153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.